Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Recruiting now · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Glaucoma

In brief

Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Key facts

Study ID

NCT07075718

Run by

Glaukos Corporation

People needed

610

Starts

2025-06-12

Expected to finish

2032-03-01

Last updated by the study team

2026-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of open-angle glaucoma or ocular hypertension in the study eye

You may not qualify if…

• Prior incisional glaucoma surgery in the study eye
• Prior argon laser trabeculoplasty (ALT) in the study eye
• Prior minimally invasive glaucoma (MIGS) surgery in the study eye

Where it is running

• Glaukos Investigative Site — Grand Junction, Colorado, United States (enrolling)
• Glaukos Investigative Site — Oklahoma City, Oklahoma, United States (enrolling)
• Glaukos Clinical Site — El Paso, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.